Office of Commercialization & Ventures
Our mission is to bring the best partners into Joslin science and clinical innovation to create a lasting impact on diabetes care.
Partnering Science for Impact
Joslin Diabetes Center is the world's pre-eminent institution dedicated to building a future without diabetes by integrating cutting-edge research, innovative clinical care and patient education.
In order to realize its vision, Joslin continues to build bridges between science and industry in its ongoing quest for better treatments and ways to prevent and cure diabetes.
The Office of Commercialization & Ventures (OCV) is a business center of Joslin Diabetes Center focused on creating strategic relationships that will expand the reach of Joslin's research and clinical expertise and promote new products and services in diabetes, its complications and obesity.
News
News | Joslin Research
- C. Ronald Kahn, M. D., Appointed Chief Academic Officer
- Joslin Diabetes Center Awarded $5 Million from Massachusetts Life Sciences Center
- Joslin Study Identifies Novel Markers as Key Indicators of Future Renal Failure in Diabetes
- Study Finds Age-related Effects in MS may be Reversible
- Joslin Researchers Uncover Mechanism That Arrests Cell Death Protein During Embryonic Development

Follow Joslin